Your shopping cart is currently empty

RET-IN-23 is an orally available and highly potent RET inhibitor with significant antitumor activity for the study of non-small cell lung cancer.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $293 | In Stock | In Stock | |
| 5 mg | $722 | In Stock | In Stock | |
| 10 mg | $987 | In Stock | In Stock | |
| 25 mg | $1,520 | In Stock | In Stock |
| Description | RET-IN-23 is an orally available and highly potent RET inhibitor with significant antitumor activity for the study of non-small cell lung cancer. |
| Targets&IC50 | RET (V804M):1.03 nM, RET (V804L):6.54 nM, RET (M918T):1.47 nM, RET (CCDC6):2.50 nM, RET (WT):1.32 nM |
| In vitro | RET-IN-23 is a potent and orally active RET inhibitor with IC50 of 1.32, 2.50, 6.54, 1.03, and 1.47 nM for RET-WT, RET-CCDC6, RET-V804L, RET-V804M, and RET-M918T, respectively. [1] |
| In vivo | RET-IN-23 exhibited significant antitumor activity in mice after oral administration at a dose of 5 mg/kg. [1] |
| Molecular Weight | 537.59 |
| Formula | C28H28FN11 |
| Cas No. | 2479961-46-9 |
| Smiles | FC=1C=NN(C1)C2=NC=C(C=C2)CN3C4CN(C5=NC=C(C=C5)C6=NC(=CC(=N6)C)NC7=NNC(=C7)C)CC3C4 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.